Evidence map›Paper›PMID 37882866›Full record

ArticleAnnals of hematology2024

Leukemic non-nodal cyclin D1- and SOX11-negative mantle cell lymphoma with CCND3::IGH rearrangement.

Lennart Tan, Goldy Bansal, Cecilia Cs Yeung, Jane Yin, Bhavana J Dave, Eric Konnick, David Wu, Kikkeri N Naresh

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Lennart TanDepartment of Pathology, Overlake Medical Center, Bellevue, WA, USA.
Goldy BansalDepartment of Medical Oncology, Fred Hutch Cancer Center at Overlake Cancer Center, Bellevue, WA, USA.
Cecilia Cs YeungSection of Pathology, Translational Science & Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jane YinDepartment of Pathology, Overlake Medical Center, Bellevue, WA, USA.
Bhavana J DaveDepartment of Pathology and Microbiology, Human Genetics Laboratory, University of Nebraska Medical Center, Omaha, NE, USA.
Eric KonnickDepartment of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA.
David WuDepartment of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA.
Kikkeri N NareshSection of Pathology, Translational Science & Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. knaresh@fredhutch.org.ORCID http://orcid.org/0000-0003-3807-3638
Overlake Hospital Medical Center · USUniversity of Washington · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAUniversity of Nebraska Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, Mantle-CellAdultBiomarkers, TumorCyclin D1Cyclin D3HumansSOXC Transcription FactorsBiomarkers, TumorCCND3 protein, humanCyclin D1Cyclin D3SOX11 protein, humanSOXC Transcription Factors

Identifiers

PMID37882866
OpenAlexW4387949838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.